Amid Strong GeneSifter Sales, VizX Sees Room for Growth in Gene-Expression Market | GenomeWeb
Although microarray vendors have recently described the gene-expression market as flat at best, at least one software vendor still sees the sector as a ripe growth opportunity.
“We think gene expression is a very key technology and is still growing,” Thomas Ranken, CEO of microarray analysis firm VizX Labs, told BioInform this week. “According to what I see, it’s increasing in the double digits, in terms of users.”

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.